— Know what they know.
Not Investment Advice
Also trades as: 0M40.L (LSE) · $vol 0M

ZYNE NASDAQ

Zynerba Pharmaceuticals, Inc.
1W: +1.6% 1M: -3.7% 3M: +271.4% 1Y: +90.9% 3Y: -64.0% 5Y: -81.4%
$1.30
Last traded 2023-10-13 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $70.1M mcap · 35M float · 3.24% daily turnover
Oct Typical
☁️
Cloudy
+0.0% YTD avg
2026 Now
☁️
Cloudy
Tracking typical
20yr Avg YTD
—
2026 YTD
—
Typical Vol
65%
Annualized
Monthly Weather Forecast
Jan
20yr
💨
+9.1%
Midterm
⛈️
-9.3%
50% win 86% vol
Feb
20yr
⛈️
-6.6%
Midterm
⛈️
-29.0%
25% win 110% vol
Mar
20yr
💨
-5.5%
Midterm
⛈️
-35.4%
38% win 214% vol
Apr
20yr
💨
+10.6%
Midterm
⛈️
-35.8%
50% win 78% vol
May
20yr
💨
+13.0%
Midterm
⛈️
-44.0%
50% win 84% vol
Jun
20yr
⛈️
+17.2%
Midterm
⛈️
-43.2%
25% win 106% vol
Jul
20yr
⛈️
+2.4%
Midterm
⛈️
-55.9%
38% win 68% vol
Aug
20yr
💨
+20.1%
Midterm
⛈️
-49.9%
78% win 356% vol
Sep
20yr
⛈️
+10.6%
Midterm
⛈️
-56.5%
33% win 96% vol
Oct
20yr
⛈️
-11.9%
Midterm
⛈️
-67.8%
44% win 65% vol
Nov
20yr
💨
-10.8%
Midterm
⛈️
-72.2%
50% win 64% vol
Dec
20yr
⛈️
-12.6%
Midterm
⛈️
-19.8%
12% win 66% vol
Seasonality (20yr)

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms